| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 55 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 55 |
| 2 | TACROLIMUS OINTMENT 0.1% | 55 |
| 3 | PREDNISONE | 50 |
| 4 | PREDNISOLONE | 42 |
| 5 | PREDNISOLONE ORAL | 42 |
| 6 | PREDNISOLONE ORAL SOLUTION | 42 |
| 7 | MYCOPHENOLATE MOFETIL | 33 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 33 |
| 9 | METHYLPREDNISOLONE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATOVAQUONE | 9 | 0.0011 |
| 1 | VALGANCICLOVIR | 20 | 0.0010 |
| 2 | PREDNISOLONE SODIUM PHOSPHATE | 2 | 0.0008 |
| 3 | MYCOPHENILIC ACID | 12 | 0.0006 |
| 4 | DASPONE | 5 | 0.0005 |
| 5 | DAPSONE GEL, 5% | 5 | 0.0005 |
| 6 | DAPSONE | 5 | 0.0005 |
| 7 | TACROLIMUS OINTMENT 0.1% | 55 | 0.0004 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 55 | 0.0004 |
| 9 | ITRACONAZOLE | 5 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Antimalarial [EPC] | 9 | 0.0009 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 19 | 0.0009 |
| 3 | Antiprotozoal [EPC] | 9 | 0.0008 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 12 | 0.0006 |
| 5 | Sulfone [EPC] | 5 | 0.0005 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 7 | Oxazolidinone Antibacterial [EPC] | 6 | 0.0002 |
| 8 | Purine Antimetabolite [EPC] | 13 | 0.0001 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |